SCH 23390: The first selective dopamine D1-like receptor antagonist

CNS Drug Reviews

Volumn 7, Issue 4, 2001, Pages 399-414

  Bourne, James A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Dopamine; Dopamine D1 receptors; Epileptiform activity; Neurological disorders; SCH 23390

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3,4 DIHYDROXYPHENYLACETIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; CHLORPROMAZINE; CLOZAPINE; DOPAMINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR; HALOPERIDOL; HOMOVANILLIC ACID; KAINIC ACID; PILOCARPINE; RECEPTOR SUBTYPE; SOMAN; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BINDING AFFINITY; BRAIN DYSFUNCTION; BRAIN ELECTROPHYSIOLOGY; BRAIN FUNCTION; DISSOCIATION CONSTANT; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; LOCOMOTION; MEMORY; MOUSE; NEUROCHEMISTRY; NONHUMAN; RAT; REVIEW; SEIZURE; TOPOGRAPHY;

EID: 0035727179     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.2001.tb00207.x     Document Type: Review

References (77)

1. 1 dopamine receptor activation reduces extracellular glutamate and GABA concentrations in the medial prefrontal cortex
2. Anticonvulsant action of SCH 23390 in the striatum of the rat
3. 2 receptors in the striatum, but not in the substantia nigra
4. 2 dopamine receptors on the expression of motor seizures in mouse and rat
5. 1 receptors
6. Mapping out of catecholamine and 5-hydroxytryptamine neurons innervating the telencephalon and diencephalon
7. Huntington's disease progression. PET and clinical observations
8. 1 receptor mechanisms in the cognitive performance of young adult and aged monkeys
9. Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: Effects of sulpiride and SCH 23390
10. Dopaminergic regulation of epileptic activity
11. 1 receptor antagonist ligand, in rat striatum
12. 2) receptors
13. Novel method of monitoring electroencephalography at the site of microdialysis during chemically evoked seizures in a freely moving animal
14. SCH 23390 affords protection against soman-evoked seizures in the freely moving guinea-pig: A concomitant neurochemical, electrophysiological and behavioural study
15. Changes in striatal electroencephalography and neurochemistry induced by kainic acid seizures are modified by dopamine receptor antagonists
16. 2 dopaminergic drugs in the mouse
17. On the neuronal circuitries and neurotransmitters involved in the control of locomotor activity
18. Seizure-related opening of the blood-brain barrier induced by soman: Possible correlation with the acute neuropathology observed in poisoned rats
19. Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: Contribution of calcium conductances
20. Dopaminergic modulation of early signs of excitotoxicity in visualized rat neostriatal neurons
21. 1 and D2 antagonists
22. 1 antagonist SCH 23390 in comparison with neuroleptics
23. 2 dopamine receptor classification and its functional implications
24. 1 receptors
25. 1 dopamine receptor increase following chronic treatment with SCH 23390
26. Influence of SCH 23390, a DA1-receptor antagonist, on the behavioural responsiveness to small and large doses of apomorphine in rats
27. Incremental changes in extracellular noradrenaline availability in the frontal cortex induced by naturalistic environmental stimuli: A microdialysis study in the freely moving rat
28. The evolution and structure of aminergic G protein-coupled receptors
29. 2 receptor antagonists on acetylcholine levels in the rat striatum
30. 11C]raclopride
31. Amphetamine-evoked dopamine release from guinea-pig striatum is potentiated by environmental stress: A need for habituation with microdialysis equipment
32. 1 receptor antagonist
33. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease
34. 1 dopaminergic receptor agents into rat prefrontal cortex
35. 2-dopamine receptors, and dopamine and its metabolites in the human brain
36. 2 interactions and non-synaptic influences
37. 1 receptors elicits akinesia in rats
38. 2 receptor blockade in the globus pallidus produces akinesia in the rat
39. 1 receptor antagonism in schizophrenia: Is there reduced risk of extrapyramidal side-effects?
40. 1 antagonist
41. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems
42. The chemical basis for the blockade of the D-1 dopamine receptor by SCH 23390
43. Heterogeneity of dopamine receptors
44. 1-dopamine receptor antagonist SCH 39166 in acutely ill schizophrenic patients
45. Multiple receptors for dopamine
46. Quantification of R-(+)-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-methyl-3- benzazepine in brain and blood by use of reversed-phase high-performance liquid chromatography with electrochemical detection
47. Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome- and matrix-enriched areas of the rat striatum
48. Glutamatergic control of dopamine release in the rat striatum: Evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals
49. Molecular characteristics of mammalian dopamine receptors
50. 2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid
51. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys
52. SCH 23390 enhances exogenous L-DOPA decarboxylation in nigrostriatal neurons
53. 1 dopamine receptor: Comparisons with the D-2 enantioselectivity of Ro 22-1319
54. 1 receptor activity
55. Dopamine and the origins of human intelligence
56. GABA and the basal ganglia
57. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats
58. 5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons
59. Novel dopamine receptors half a decade later
60. 3) as a target for neuroleptics
61. 2 dopamine receptors in non-habituated mice
62. 3H]aminobutyric acid release?
63. The role of dopamine in epilepsy
64. 1
65. 1B receptor subtype
66. In vivo microdialysis evidence for transient dopamine release by benzazepines in rat striatum
67. The seizures induced by pilocarpine: Behavioral, electroencephalographic and neuropathological studies in rodents
68. 4 receptor with high affinity for the antipsychotic clozapine
69. 1 dopamine receptor agonists and antagonists in psychiatry and neurology
70. 1 antagonist
71. Motor consequences of D-1 dopamine receptor stimulation and blockade
72. 2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease
73. Brain microdialysis and its application for the study of animal behaviour
74. On the mechanism of neuroleptic induced increase in striatal dopamine release: Brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals
75. 1 receptors in prefrontal cortex
76. 1 receptor actions in layers V-VI rat prefrontal cortex neurons in vitro: Modulation of dendritic-somatic signal integration
77. 2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo